Oct. 26, 2023 – Firms advertising and marketing costly and unproven stem cell therapies are concentrating on sufferers with lengthy COVID – an typically debilitating situation that to this point has no confirmed therapies, in accordance with a report printed at the moment.
Researchers recognized 38 direct-to-consumer companies promoting purported stem cell therapies to forestall and deal with the virus – 36 of which additionally declare to deal with post-COVID syndrome.
“There’s an necessary alternative right here for regulators to know there are nonetheless fairly a lot of companies making problematic promoting claims,” stated Leigh Turner, PhD, the primary writer of a research on the difficulty and a bioethics professor on the College of California, Irvine Division of Well being, Society, and Conduct. “I do not assume that is going to go away anytime quickly. It must be a excessive precedence.”
Stem cells, generally known as the physique’s “grasp cells,” can generate new cell varieties – one thing no different cell within the physique can do. And whereas they’ve the potential to restore and regenerate cells, these therapies haven’t been authorised by regulatory our bodies and usually are not backed by convincing security and efficacy information.
The FDA issued a warning in 2019 towards stem cell therapies to deal with COVID-19.
Of the 60 clinics operated by these companies, 24 are based mostly within the U.S. and 22 are in Mexico, with different clinics within the Cayman Islands, Guatemala, Malaysia, Panama, the Philippines, Poland, Spain, Thailand, Ukraine, and the United Arab Emirates.
“It was attention-grabbing to me the extent to which these have been companies working within the U.S., not in far-flung locations,” Turner stated.
In response to the report, clinics cost wherever from $2,950 to $25,000 for stem cell merchandise.
Many individuals with lengthy COVID take care of signs similar to mind fog, excessive fatigue, and extreme complications that linger for months and even years. One in 10 individuals with the virus will get post-COVID syndrome. The severity of the signs, and the dearth of therapies, make sufferers significantly weak to false claims, stated Kristin Englund, MD, an infectious illness specialist who runs the Cleveland Clinic’s reCOVer clinic for lengthy COVID sufferers.
Englund stated a number of sufferers have requested about stem cell therapies, and she or he warns them that there might be potential unwanted side effects with out a lot, if any, profit. Firms typically attempt to declare a medical profit with out scientific proof and with out being acknowledged by a regulatory company, she stated.
“Once you work with this inhabitants, you see how determined they’ll get to return to the lives they lived pre-COVID,” she stated. “Among the sufferers we’re seeing, they have been happening 3 years with these signs. Right now, there isn’t any single prognosis, no single therapy, and that’s tremendously irritating for sufferers.”
Julia Moore Vogel, PhD, a computational biologist and researcher at Scripps Analysis, has seen this drawback by way of each a affected person and scientist lens. Earlier than catching the virus in July 2020, the 38-year-old was a long-distance runner. Now, after coping with lengthy COVID for 3 years, she counts her steps so she does not get too drained.
And whereas she has tried potential low-risk therapies like dietary supplements – which did not work for her – she wouldn’t use stem cell therapies, given the dearth of strong analysis.
“I in fact keep in mind, in class, stem cell therapies being one thing that was very a lot an space of curiosity,” she stated. “I’d simply actually need to see the information earlier than I may really feel assured about attempting it.”
Although the Nationwide Institutes of Well being has launched a number of scientific trials targeted on treating lengthy COVID, and the FDA has approved a number of stem cell scientific trials for lengthy COVID, there’s nonetheless a lot to find out about post-viral syndromes on the whole, stated Michael R. Jordan, MD, an infectious illness physician at Tufts College in Medford, MA.
“There are a variety of observational cohort research and scientific trials in progress to evaluate varied therapies for lengthy COVID,” he stated. “However what’s necessary is there isn’t any confirmed therapy at this level, and proposals are for sufferers to work with licensed certified and skilled well being care suppliers for symptom administration.”
